Vaccine shifts rotavirus transmission
Posted on: Friday, 17 July 2009, 00:53 CDT
Vaccines for rotavirus, which causes diarrhea, have implications for combating illness in the United States and temper epidemics worldwide, U.S. officials say.
The research, published in the journal Science, is based on mathematical modeling that takes into account regional birth rates and predicted vaccination levels and effectiveness.
Lead investigator Umesh D. Parashar of the Centers for Disease Control and Prevention said the model suggests that when 80 percent or more of children in a given population are vaccinated, annual epidemics may occur on a less regular basis and more unvaccinated children will be protected.
Data from 2007-2008, when vaccination first reached appreciable coverage levels in the United States, validate the model's predictions, the researchers said.
Rotavirus vaccines have rapidly and dramatically reduced hospitalizations and emergency room visits for gastroenteritis in American children,
Parashar said in a statement.
This research not only explains the effects of the U.S. rotavirus vaccination program, but also lays the foundation for understanding the tremendous life-saving benefits of vaccination in the developing world, where more than half a million children die from rotavirus each year.
Source: United Press International
Related Articles
- Federal Advisory Committee Votes to Include Newly Licensed Pentacel(R) Vaccine in Vaccines for Children Program
- Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
- ROTATEQ(R) and GARDASIL(R) Adopted By All Immunization Projects of the Centers for Disease Control and Prevention's (CDC) Vaccines for Children (VFC) Program
- Studies Fail to Demonstrate Safety or Effectiveness of Influenza Vaccine in Children and Adults
- Singapore Urges Parents to Vaccinate Their Children againstMMR
- Nepali Gov't Provides Vaccines to Children to Reduce Child Mortality
- CDC's Advisory Committee Recommends Expanded Influenza Vaccinations for Children
- CDC Advisory Committee on Immunization Practices Votes to Recommend Inclusion of ROTATEQ(R) in the Vaccines for Children (VFC) Program
- Vaccine Against Children Diarrhea Wins FDA Approval
- Effectiveness of the 2003-2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 Vs 2 Doses
User Comments (0)

RSS Feeds